Selwin Wu (He/Him)

Associate Editor, Springer Nature
  • Singapore

About Selwin Wu

Selwin led studies that challenged prevailing models of inflammaging and how physical forces drive the spread of cancer. He oversaw the development and model training of an artificial intelligence-assisted imaging analysis pipeline to study cancer invasion. His publications include lead and senior author articles in Nature Cell Biology, Aging Cell, Molecular Biology of the Cell, and Developmental Cell. Besides prior guest editing for open-access journals, he has contributed to peer review for journals including Science, Nature Reviews Cancer and the Journal of Clinical Investigation.

He completed his PhD at the University of Queensland. During his postdoctoral training at Harvard Medical School, the HHMI, and the Dana-Farber Cancer Institute, he received a Leukemia & Lymphoma Society Fellow Award. Upon returning to Singapore, he was awarded a Principal Investigatorship under the National Medical Research Council's Young Individual Research Grant.

Selwin joined Springer Nature, Singapore, in September 2025, to oversee several journals in the medicine and life sciences portfolio of Discover.

Online Elsewhere